Loading the section…
The price of Anixa Biosciences, Inc. (ANIX) on October 9, 2026 is 2.90 USD, −0.34% on the day. Over 52 weeks the stock traded between 2.32 USD and 5.46 USD; the price now sits 18% of the way up that range. Over the past year the price changed by −34.68%. Market capitalization is 98.37 million USD, rank 219 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −35.84 %
Anixa Biosciences, Inc. trades on Nasdaq under the ticker ANIX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ANIX has traded between 2.32 $ and 5.46 $. As of 9 October 2026 the price stood 18.47 % of the way from the 52-week low to the high.
Over one year ANIX shares fell 34.68 %; over six months they rose 7.81 %. Volatility over 90 days is 60.75 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 468, above the sector median of 4.0. Price to book is 6.8, above the sector median of 2.5. Calculated from reports for the period ending 30 April 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 2.93 | 2.96 | 2.86 | 2.90 | 217,900 |
| 8 October 2026 | 2.93 | 2.93 | 2.86 | 2.91 | 259,600 |
| 7 October 2026 | 3.01 | 3.06 | 2.93 | 2.95 | 245,200 |
| 6 October 2026 | 2.95 | 3.11 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 April 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118, US
Anixa Biosciences, Inc. reported revenue of 210,000 $ and a net loss of 10M $ over the last four quarters. Earnings per share are −0.30 $. Market capitalisation is 98M $.
ANIX has a return on equity of −69.32 %, below the sector median of −41.68 %. Return on assets is −67.50 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 2.87 |
| 3.02 |
| 344,900 |
| 5 October 2026 | 2.98 | 2.99 | 2.88 | 2.95 | 369,300 |
| 2 October 2026 | 2.83 | 2.95 | 2.77 | 2.95 | 433,300 |
| 1 October 2026 | 2.93 | 2.93 | 2.74 | 2.77 | 290,400 |
| 30 September 2026 | 2.85 | 2.95 | 2.81 | 2.93 | 428,900 |
| 29 September 2026 | 2.79 | 2.85 | 2.72 | 2.85 | 183,200 |
| 28 September 2026 | 2.78 | 2.83 | 2.70 | 2.79 | 305,500 |
| 25 September 2026 | 2.85 | 2.87 | 2.69 | 2.78 | 360,800 |
| 24 September 2026 | 2.74 | 2.81 | 2.72 | 2.78 | 257,700 |
| 23 September 2026 | 2.77 | 2.81 | 2.62 | 2.75 | 391,100 |
| 22 September 2026 | 2.73 | 2.79 | 2.68 | 2.79 | 434,100 |
| 21 September 2026 | 2.82 | 2.82 | 2.66 | 2.70 | 476,300 |
| 18 September 2026 | 2.78 | 2.79 | 2.69 | 2.77 | 315,200 |
| 17 September 2026 | 2.66 | 2.76 | 2.64 | 2.76 | 345,600 |
| 16 September 2026 | 2.70 | 2.72 | 2.56 | 2.60 | 557,400 |
| 15 September 2026 | 2.80 | 2.80 | 2.66 | 2.69 | 353,700 |
| 14 September 2026 | 2.79 | 2.88 | 2.76 | 2.80 | 376,400 |